SPY335.57+1.00 0.30%
DIA278.14+3.52 1.28%
IXIC10,968.36-42.63 -0.39%

J&J Says First-in-human Phase 1/2a Clinical Trial Now Underway in United States and Belgium; Phase 3 Clinical Trial Expected to Commence in September

Benzinga · -